Abpro Holdings Inc.
ABPO
Abpro Holdings, Inc. (together with its subsidiaries, the Company ) is a biotechnology company dedicated to developing next-generation antibody therapeutics to improve the lives of patients with severe and life-threatening diseases. The Company is focused on the development of novel antibodies using its proprietary discovery and engineering platforms, primarily in the areas of immuno-o…
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
$2M
▲ +60.0% YoY
Op. Margin
–
ROIC
-3701.22%
▼ -234.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$7M
▲ +33.5% YoY
Op. Cash Flow (TTM)
-$7M
▲ +33.5% YoY
Net Debt
-$4M
Net Cash Position
Cash & Equiv.
$4M
Continue Research
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with ABPO
Abpro Holdings (ABPO) in three numbers
Questions about Abpro Holdings
Is Abpro Holdings (ABPO) overvalued?
Abpro Holdings trades at 0.42 times earnings. Intrinsiqq's fair value calculator has no opening value for ABPO, so weigh those multiples against the company's own history and the peers above. See how to tell if a stock is overvalued.
Is Abpro Holdings a high-quality business?
Abpro Holdings scores 35 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 7 checks computed from SEC filings. Its best check is revenue growth at 50.0%, and its weakest is return on capital at -3701.2%. The Quality tab shows every check against its target.
Does Abpro Holdings (ABPO) pay a dividend?
No. Abpro Holdings (ABPO) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 14 Aug 2026 (period ending 30 Jun 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in ABPO's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ABPO
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.